Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
1
Trials led
0
Active
42
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Trials by status
Completed
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)Healthy volunteersPh 4Completed42